Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Financing Activities ₹-1,543 Cr₹-524 Cr₹-696 Cr₹-428 Cr₹-358 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-1,543 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Financing Activities
Mar2023₹-1,543 Cr
Mar2022₹-524 Cr
Mar2021₹-696 Cr
Mar2020₹-428 Cr
Mar2019₹-358 Cr

How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2023 ₹-1,543 Cr
Negative
Mar2022 ₹-524 Cr
Negative
Mar2021 ₹-696 Cr
Negative
Mar2020 ₹-428 Cr
Negative
Mar2019 ₹-358 Cr -

Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹36,128.8 Cr 9.5% 8.6% 64.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,920.0 Cr -2.3% -6.5% 55.3% Stock Analytics
CIPLA ₹113,794.0 Cr 4.1% -4.8% 55.6% Stock Analytics
DIVIS LABORATORIES ₹106,860.0 Cr 7.8% 17.4% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,316.0 Cr 4% 0.8% 29.4% Stock Analytics
ZYDUS LIFESCIENCES ₹95,380.9 Cr -1.2% -5.2% 83.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

9.5%

8.6%

64.8%

SENSEX

0.9%

1.5%

23.6%


You may also like the below Video Courses